Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Apr 2021
Historique:
received: 16 03 2021
revised: 02 04 2021
accepted: 07 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 25 5 2021
Statut: epublish

Résumé

Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder caused by the deposition of amyloid beta-peptide (Aβ) aggregates. Aβ aggregates lead to vessel rupture and intracerebral hemorrhages, detected by magnetic resonance imaging (MRI). Presenile CAA is usually genetically determined by mutations in the amyloid precursor protein (

Identifiants

pubmed: 33918046
pii: ijms22083870
doi: 10.3390/ijms22083870
pmc: PMC8069161
pii:
doi:

Substances chimiques

PSEN1 protein, human 0
Presenilin-1 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Références

Circ Res. 2017 Feb 3;120(3):573-591
pubmed: 28154105
Neurol Sci. 2012 Apr;33(2):375-8
pubmed: 21822699
Nat Rev Neurol. 2020 Jan;16(1):30-42
pubmed: 31827267
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
J Neurol. 1995 Sep;242(9):557-60
pubmed: 8551316
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Am J Pathol. 2001 Jun;158(6):2165-75
pubmed: 11395394
J Clin Med. 2018 Dec 22;8(1):
pubmed: 30583522
J Alzheimers Dis. 2012;30(4):847-56
pubmed: 22475797
Curr Opin Psychiatry. 2016 Mar;29(2):168-73
pubmed: 26779861
Clin Imaging. 2021 Jun;74:45-54
pubmed: 33434866
Eur J Neurol. 2020 Dec;27(12):2630-2634
pubmed: 32894632
Bioinformatics. 2019 Jun 1;35(11):1978-1980
pubmed: 30376034

Auteurs

Ilaria Palmieri (I)

Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.
Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.

Marialuisa Valente (M)

Laboratory of Clinical Pathology Microbiology and Genetics, SS. Annunziata Hospital, 74100 Taranto, Italy.

Lisa Maria Farina (LM)

Advanced Imaging and Radiomics Center, Neuroradiology Department, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Simone Gana (S)

Medical Genetics Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Brigida Minafra (B)

Parkinson and Movement Disorders Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Roberta Zangaglia (R)

Parkinson and Movement Disorders Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Orietta Pansarasa (O)

Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Daisy Sproviero (D)

Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Alfredo Costa (A)

Unit of Behavioral Neurology, IRCCS Mondino Foundation, 27100 Pavia, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.

Claudio Pacchetti (C)

Parkinson and Movement Disorders Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Anna Pichiecchio (A)

Advanced Imaging and Radiomics Center, Neuroradiology Department, IRCCS Mondino Foundation, 27100 Pavia, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.

Stella Gagliardi (S)

Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Cristina Cereda (C)

Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH